J&J Has 'Tremendous, Deep Bench' of Leaders, CEO Says

The video discusses Johnson & Johnson's substantial investment in research and development, highlighting their position among top companies globally. It covers leadership changes, including the retirement of Chief Scientific Officer Paul Stoffels and the appointment of new leaders. The video also explains the strategic decision to divide the company, emphasizing the need to adapt to changing market dynamics and unlock potential in consumer brands and other business sectors.

How much is Johnson & Johnson investing in research and development this year?

• $10 billion

• $14 billion

• $20 billion

• $5 billion

Who is stepping down from the position of Chief Scientific Officer at Johnson & Johnson?

• Dr. Bill Height

• Dr. Mattie Mom

• Dr. Paul Stoffels

• Dr. John Doe

What is the significance of adding Dr. Bill Height and Dr. Mattie Mom to the executive committee?

• To focus on marketing strategies

• To increase the voice of science in leadership

• To expand the company's global presence

• To reduce the company's expenses

What was the main reason behind the decision to divide Johnson & Johnson?

• Ongoing discussions with the Board of Directors

• A sudden market change

• A new competitor in the market

• The pandemic

What potential does Johnson & Johnson see in dividing the company?

• Focusing solely on pharmaceuticals

• Reducing the workforce

• Unlocking potential in consumer brands

• Increasing product prices